European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis
- PMID: 37409332
- PMCID: PMC11138169
- DOI: 10.1136/flgastro-2022-102296
European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis
Abstract
The European Association for the Study of the Liver has recently updated guidance on haemochromatosis with a more extensive discussion on investigation and management.[ The new guidance focuses on non-invasive methods for fibrosis assessment and early diagnosis to include more extensive genetic testing if needed. Early diagnosis and treatment is vital as it reduces morbidity and mortality. We review this guideline and offer key updated messages with a focus on new developments since the last guidance and key aspects of current practice.
Keywords: HAEMOCHROMATOSIS; LIVER; LIVER CIRRHOSIS.
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Haemochromatosis UK . Diagnosis and care. Available: www.haemochromatosis.org.uk/diagnosis-and-care-by-gps [Accessed Aug 2022].
LinkOut - more resources
Full Text Sources